1. Home
  2. JAGX vs KWE Comparison

JAGX vs KWE Comparison

Compare JAGX & KWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • KWE
  • Stock Information
  • Founded
  • JAGX 2013
  • KWE 2017
  • Country
  • JAGX United States
  • KWE Canada
  • Employees
  • JAGX N/A
  • KWE N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • KWE
  • Sector
  • JAGX Health Care
  • KWE
  • Exchange
  • JAGX Nasdaq
  • KWE Nasdaq
  • Market Cap
  • JAGX 3.8M
  • KWE 3.2M
  • IPO Year
  • JAGX N/A
  • KWE N/A
  • Fundamental
  • Price
  • JAGX $10.91
  • KWE $5.14
  • Analyst Decision
  • JAGX
  • KWE
  • Analyst Count
  • JAGX 0
  • KWE 0
  • Target Price
  • JAGX N/A
  • KWE N/A
  • AVG Volume (30 Days)
  • JAGX 211.5K
  • KWE 423.8K
  • Earning Date
  • JAGX 05-13-2025
  • KWE 05-15-2025
  • Dividend Yield
  • JAGX N/A
  • KWE N/A
  • EPS Growth
  • JAGX N/A
  • KWE N/A
  • EPS
  • JAGX N/A
  • KWE N/A
  • Revenue
  • JAGX $11,689,000.00
  • KWE $1,572,738.00
  • Revenue This Year
  • JAGX $38.22
  • KWE N/A
  • Revenue Next Year
  • JAGX $39.96
  • KWE N/A
  • P/E Ratio
  • JAGX N/A
  • KWE N/A
  • Revenue Growth
  • JAGX 19.75
  • KWE 116.30
  • 52 Week Low
  • JAGX $4.02
  • KWE $0.22
  • 52 Week High
  • JAGX $540.00
  • KWE $243.60
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 70.55
  • KWE 49.11
  • Support Level
  • JAGX $5.00
  • KWE $0.22
  • Resistance Level
  • JAGX $6.13
  • KWE $7.20
  • Average True Range (ATR)
  • JAGX 1.37
  • KWE 0.64
  • MACD
  • JAGX 0.94
  • KWE 0.17
  • Stochastic Oscillator
  • JAGX 60.12
  • KWE 70.50

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About KWE KWESST Micro Systems Inc.

KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.

Share on Social Networks: